Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1659 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Novartis Pharma Q1 Net Sales Up 25%

Novartis Pharma posted a net income of $2.95bn for the first quarter 2010, or $1.29 per diluted share, an increase of 49%, compared to $1.97bn, or $0.87 per

Biogen Idec Q1 Total Revenues Up 7%

Biogen Idec posted a net income of $219.99m for the first quarter 2010, or $0.80 per diluted share, compared to $246.57m, or $0.84 per diluted share, for the